文献速递类风湿关节炎

类风湿关节炎患者循环微生物小RNA发生改变

Circulating microbial small RNAs are altered in patients with rheumatoid arthritis.
PubMed 文献 · Ann Rheum Dis · 2020-09-21

该研究对165例RA患者和90名匹配对照的血浆进行小RNA测序,并分析70例RA患者起始DMARD治疗前后的样本。结果显示多种细菌基因组计数在RA患者血浆中显著降低,3种微生物tRNA来源小RNA升高且与疾病活动度负相关,基线微生物小RNA总量较高与DMARD治疗6个月后疾病活动度改善相关。

要点

  • RA患者血浆中多种细菌基因组计数较对照显著降低。
  • 3种微生物tRNA来源小RNA在RA中升高且与疾病活动度负相关。
  • 基线微生物小RNA总量较高与DMARD治疗6个月后疾病活动度改善相关。

核心结论

  • RA患者血浆微生物小RNA组成较对照改变,且与部分RA疾病活动度指标相关。
  • DMARD治疗不改变微生物小RNA丰度或组成,但基线微生物小RNA丰度较高与6个月时疾病活动度改善相关。

研究设计与样本

  • 对165例RA患者和90名匹配对照的血浆进行小RNA测序,并对另一队列70例RA患者起始DMARD治疗前后进行测序。
  • 对RA相关细菌、代表性细菌和真菌人类微生物组基因组及环境细菌进行基因组比对,错误发现率设定为0.05。

主要发现

  • Lactobacillus salivarius、Anaerobaculum hydrogeniformans、Staphylococcus epidermidis、Staphylococcus aureus、Paenisporosarcina spp、Facklamia hominis、Sphingobacterium spiritivorum、Lentibacillus amyloliquefaciens、Geobacillus spp和Pseudomonas fluorescens的基因组计数在RA患者血浆中较对照显著降低。
  • 3种微生物转运RNA来源小RNA在RA中较对照升高,且与疾病活动度呈负相关。
  • 较高的总微生物小RNA reads与RA较低疾病活动度相关。
  • 基线总微生物小RNA在DMARD治疗后改善的患者中较未改善者高3倍,但治疗6个月后无显著变化。

临床怎么用

  • 血浆微生物小RNA可能作为RA疾病活动度及DMARD治疗反应的潜在生物标志物,但尚需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine if plasma microbial small RNAs (sRNAs) are altered in patients with rheumatoid arthritis (RA) compared with control subjects, associated with RA disease-related features, and altered by disease-modifying antirheumatic drugs (DMARDs). METHODS: sRNA sequencing was performed on plasma from 165 patients with RA and 90 matched controls and a separate cohort of 70 patients with RA before and after starting a DMARD. Genome alignments for RA-associated bacteria, representative bacterial and fungal human microbiome genomes and environmental bacteria were performed. Microbial genome counts and individual sRNAs were compared across groups and correlated with disease features. False discovery rate was set at 0.05. RESULTS: Genome counts of Lactobacillus salivarius, Anaerobaculum hydrogeniformans, Staphylococcus epidermidis, Staphylococcus aureus, Paenisporosarcina spp, Facklamia hominis, Sphingobacterium spiritivorum, Lentibacillus amyloliquefaciens, Geobacillus spp, and Pseudomonas fluorescens were significantly decreased in the plasma of RA compared with control subjects. Three microbial transfer RNA-derived sRNAs were increased in RA versus controls and inversely associated with disease activity. Higher total microbial sRNA reads were associated with lower disease activity in RA. Baseline total microbial sRNAs were threefold higher among patients who improved with DMARD versus those who did not but did not change significantly after 6 months of treatment. CONCLUSION: Plasma microbial sRNA composition is altered in RA versus control subjects and associated with some measures of RA disease activity. DMARD treatment does not alter microbial sRNA abundance or composition, but increased abundance of microbial sRNAs at baseline was associated with disease activity improvement at 6 months.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Ormseth MJ, Wu Q, Zhao S, et al. Circulating microbial small RNAs are altered in patients with rheumatoid arthritis. Ann Rheum Dis. 2020. PMID: 32958509. doi:10.1136/annrheumdis-2020-217589

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。